EUVIMEDEUVIMED entdecken
Open Access

A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels

Erjia Guo iD, Li Chen iD, Yongliang Li, Peilin Fan, Yi Xie, Xinrong Fan, Lin Ma, Xiaoyuan Li, Yushi Yang, Houfeng Huang, Lili Xu iD, Hao Sun iD und 1 weitere

Journal of Magnetic Resonance Imaging · 2026

DOI: 10.1002/jmri.70401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2026. Verfasst von Erjia Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical S…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Magnetic Resonance Imaging, Ureter. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Beijing Natural Science Foundation, the Peking Union Medical College Hospital Talent Cultivation Program (Category D), the CAMS Innovation Fund for Medical Sciences (CIFMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While the current Vesical Imaging Reporting and Data System (VI‐RADS) provides a valuable tool for evaluating bladder cancer, it is not tailored to the ureteral orifices and primarily relies on subjective evaluation.

Purpose

To identify significant parameters from MRI for diagnosing muscle‐invasive bladder cancer (MIBC) at the ureteral orifice, and to evaluate their incremental value to VI‐RADS for readers of varying experience. Study Type Retrospective. Population Development cohort: 81 patients with ureteral orifice bladder tumors (mean age, 68 ± 9; 60 men). External validation cohort: 34 patients (mean age, 63 ± 5; 22 men). Field Strength/Sequence 3.0 T; fast spin‐echo T2‐weighted imaging, single‐shot echo planar diffusion‐weighted imaging, 3D spoiled gradient echo T1‐weighted dynamic contrast‐enhanced imaging. Assessment Four radiologists of varying experience independently assigned VI‐RADS scores. Quantitative parameters (tumor length, tumor contact length [TCL], stalk width [SW], and K trans ) and qualitative parameters were assessed. Pathology was the reference standard. Statistical Tests Intraclass correlation coefficient, weighted κ analysis, independent samples t ‐test, Mann–Whitney U test, chi‐square test, receiver operating characteristic curve analysis, univariate and multivariate logistic regression, 1000 bootstrap resamples, DeLong's test, and McNemar's test with Bonferroni correction. Significance was defined as p < 0.05, with p < 0.008 for multiple comparisons.

Results

Multivariate analysis identified TCL (odds ratio [OR] = 1.12) and stalk width (OR = 1.74) as independent predictors. In both cohorts, the TCL + SW‐modified VI‐RADS significantly improved sensitivity over the original VI‐RADS for diagnosing MIBC at the ureteral orifice in two junior radiologists. The TCL + SW‐modified VI‐RADS did not significantly improve sensitivity compared with the TCL‐modified VI‐RADS in either cohort ( p = 0.25–0.50). Data Conclusion The integration of TCL and stalk width into the VI‐RADS improves diagnostic performance for MIBC at the ureteral orifice, particularly for less‐experienced radiologists. Nevertheless, external validation in larger, multicenter cohorts is required. Evidence Level 3. Technical Efficacy Stage 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsMagnetic Resonance ImagingUreterHumansMaleFemaleAgedRetrospective StudiesMiddle AgedReproducibility of ResultsDiffusion Magnetic Resonance ImagingSensitivity and SpecificityUrinary BladderContrast MediaObserver VariationImage Interpretation, Computer-AssistedROC Curve

Stichwörter der Autor:innen

bladder cancermagnetic resonance imagingstalk widthtumor contact lengthvesical imaging reporting and data system

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Radiology, The Fourth People's Hospital of Jinan, Jinan, Shandong Province, China.
  • Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

ORCID-Profile: Erjia Guo, Li Chen, Lili Xu, Hao Sun, Gumuyang Zhang

Förderung

  • the Beijing Natural Science Foundation
  • the Peking Union Medical College Hospital Talent Cultivation Program (Category D)
  • the CAMS Innovation Fund for Medical Sciences (CIFMS)
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Guo, E., Chen, L., Li, Y., Fan, P., Xie, Y., Fan, X., Ma, L., Li, X., Yang, Y., Huang, H., Xu, L., Sun, H., & Zhang, G. (2026). A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.70401

Vancouver

Guo E, Chen L, Li Y, Fan P, Xie Y, Fan X, et al. A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels. Journal of Magnetic Resonance Imaging. 2026. doi:10.1002/jmri.70401

BibTeX
@article{Guo2026,
  author = {Guo, Erjia and Chen, Li and Li, Yongliang and Fan, Peilin and Xie, Yi and Fan, Xinrong and Ma, Lin and Li, Xiaoyuan and Yang, Yushi and Huang, Houfeng and Xu, Lili and Sun, Hao and Zhang, Gumuyang},
  title = {A Quantitative Modification of VI ‐ RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience Levels},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2026},
  doi = {10.1002/jmri.70401}
}
Kostenlos starten →